Insulin-like growth factor binding protein-1 regulates HIF-1α degradation to inhibit apoptosis in hypoxic...

Area of Science:

• Cardiovascular Science
• Molecular Biology
• Cellular Physiology

Background:

• Hypoxia plays a critical role in ischemic heart disease.
• Elevated Insulin-like growth factor binding protein-1 (IGFBP-1) levels are implicated in cardiomyocyte damage during acute myocardial infarction.
• The precise mechanisms of IGFBP-1's effects on cardiomyocytes are not fully understood.

Purpose of the Study:

• To elucidate the role of IGFBP-1 in hypoxia-induced cardiomyocyte apoptosis.
• To investigate the relationship between IGFBP-1 and Hypoxia-inducible factor 1-alpha (HIF-1α) in cardiomyocytes.
• To identify potential therapeutic targets for ischemic heart disease based on the IGFBP-1-HIF-1α pathway.

Main Methods:

• Investigated the effect of hypoxia on IGFBP-1 and HIF-1α protein expression in cardiomyocytes.
• Utilized IGFBP-1 suppression and HIF-1α overexpression techniques.
• Examined the interaction between IGFBP-1 and Von Hippel-Lindau (VHL) protein to understand HIF-1α stabilization.

Main Results:

• Hypoxia was found to up-regulate both IGFBP-1 and HIF-1α protein expression in cardiomyocytes.
• Suppression of IGFBP-1 reduced HIF-1α expression and inhibited hypoxia-induced apoptosis, effects reversible by HIF-1α overexpression.
• IGFBP-1 was shown to regulate HIF-1α stabilization by interacting with VHL.

Conclusions:

• HIF-1α is essential for the function of IGFBP-1 in regulating cardiomyocyte apoptosis under hypoxic conditions.
• The interaction between IGFBP-1 and VHL is a key mechanism for IGFBP-1's regulation of HIF-1α stabilization.
• The IGFBP-1-HIF-1α signaling axis presents a promising therapeutic target for managing ischemic heart disease.